Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.70 |
| ▸ | TP53 | P04637 | 1/20 | 0.70 |
| ▸ | APP | P05067 | 1/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.70 |
| ▸ | SNCA | P37840 | 1/20 | 0.70 |
| ▸ | BLM | P54132 | 1/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.70 |
| ▸ | GAA | P10253 | 6/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.69 |
| ▸ | MEN1 | O00255 | 4/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29414661 | 1.00 | MAPT (0.70) | MAPTKDM4ESMN1; SMN2TP53APP | |
| SCHEMBL3980084 | 0.89 | MAPT (0.61) | MAPTKDM4ESMN1; SMN2TP53APP | |
| SCHEMBL4607773 | 0.89 | MAPT (0.86) | MAPTKDM4ESMN1; SMN2TP53APP | |
| SCHEMBL6651517 | 0.87 | MAPK13 (0.79) | MAPTKDM4ESMN1; SMN2TP53APP | |
| SCHEMBL17382717 | 0.84 | MAPT (0.53) | MAPTKDM4ESMN1; SMN2TP53APP | |
| SCHEMBL1636651 | 0.83 | MAPT (1.00) | MAPTKDM4ESMN1; SMN2TP53APP | |
| SCHEMBL9396738 | 0.83 | MAPT (0.91) | MAPTKDM4ESMN1; SMN2TP53APP | |
| SCHEMBL4647245 | 0.83 | MAPT (0.76) | MAPTKDM4ESMN1; SMN2TP53APP | |
| SCHEMBL217480 | 0.82 | MAPT (1.00) | MAPTKDM4ESMN1; SMN2TP53APP | |
| SCHEMBL29388147 | 0.82 | MAPT (1.00) | MAPTKDM4ESMN1; SMN2TP53APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4700021-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT | Sapiensbio Inc. (KR) | 2026-02-25 | — | — | EP | disclosed |
| EP-4538270-A1 | NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT | Sapiensbio Inc. (KR) | 2025-04-16 | — | — | EP | disclosed |
| WO-2023239227-A1 | NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT | 주식회사 사피엔스바이오 | 2023-12-14 | — | — | WO | disclosed |
| CN-111747933-B | Substituted 1,3, 5-triazine compound, composition and application thereof | 吉林省元合电子材料有限公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-111747937-B | 1,3, 5-triazine compound, composition and application thereof | 吉林省元合电子材料有限公司 | 2022-01-14 | — | — | CN | disclosed |
| CN-111747936-B | Substituted 1,3, 5-triazine compound, composition and application thereof | 吉林省元合电子材料有限公司 | 2021-10-22 | — | — | CN | disclosed |
| CN-111747936-A | Substituted 1,3, 5-triazine compound, composition and application thereof | 吉林省元合电子材料有限公司 | 2020-10-09 | — | — | CN | disclosed |
| CN-111747933-A | Substituted 1,3, 5-triazine compound, composition and application thereof | 吉林省元合电子材料有限公司 | 2020-10-09 | — | — | CN | disclosed |
| CN-111747937-A | 1,3, 5-triazine compound, composition and application thereof | 吉林省元合电子材料有限公司 | 2020-10-09 | — | — | CN | disclosed |
| WO-2020199998-A1 | 1,3,5-TRIAZINE COMPOUND AND COMPOSITION, AND APPLICATION THEREOF | 吉林省元合电子材料有限公司 | 2020-10-08 | — | — | WO | disclosed |
| US-5580895-A | GASTROINTESTINAL OR CENTRAL NERVOUS SYSTEM DISORDERS | GLAXO SPA (IT) | 1996-12-03 | — | — | US | disclosed |
| US-5486514-A | GASTRIN, CHOLECYSTOKININ RECEPTOR ANTAGONISTS | GLAXO SPA (IT) | 1996-01-23 | — | — | US | disclosed |
| EP-0623118-A1 | CARBAMATE DERIVATIVES AND THEIR USE IN MEDICINE | GLAXO S.p.A. (IT) | 1994-11-09 | — | — | EP | disclosed |
| CN-1077952-A | CARBAMATE DERIVATIVES | GLAXO SPA (IT) | 1993-11-03 | — | — | CN | disclosed |
| EP-0356176-B1 | ACETAMIDE COMPOUNDS | HAMARI YAKUHIN KOGYO KABUSHIKI KAISHA also known as HAMARI CHEMICALS, LTD. (JP) | 1993-09-22 | — | — | EP | disclosed |
| EP-0558104-A1 | 1,5-Benzodiazepine derivatives and their use in medicine | GLAXO S.p.A. (IT) | 1993-09-01 | — | — | EP | disclosed |
| CN-1074678-A | 1, the 5-benzodiazepine derivatives | GLAXO SPA (IT) | 1993-07-28 | — | — | CN | disclosed |
| WO-1993014075-A1 | CARBAMATE DERIVATIVES AND THEIR USE IN MEDICINE | GLAXO SPA (IT) | 1993-07-22 | — | — | WO | disclosed |
| US-4950667-A | Pyridinyl acetamide compounds useful in treating ulcers | HAMARI CHEMICALS, LTD. (JP) | 1990-08-21 | — | — | US | disclosed |
| EP-0356176-A1 | Acetamide compounds | HAMARI YAKUHIN KOGYO KABUSHIKI KAISHA also known as HAMARI CHEMICALS, LTD. (JP) | 1990-02-28 | — | — | EP | disclosed |